Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if SION is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
39 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 24 days ago
Red flags: 0
147 filers reported a long position in SION for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $435.7M | 9.9M | Unchanged |
| TPG GP A, LLC | $285.7M | 6.5M | Unchanged |
| VIKING GLOBAL INVESTORS LP | $140.6M | 3.2M | Unchanged |
| Atlas Venture Life Science Advisors, LLC | $131.8M | 3M | Unchanged |
| ORBIMED ADVISORS LLC | $112.4M | 2.6M | -27.6% |
| Enavate Sciences GP, LLC | $109M | 2.5M | Unchanged |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $70.4M | 1.6M | +966.7% |
| BlackRock, Inc. | $64.9M | 1.5M | +13.8% |
| JPMORGAN CHASE & CO | $64.1M | 1.5M | +1.7% |
| JENNISON ASSOCIATES LLC | $51.6M | 1.2M | -19.2% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.